Stock screenerAll disclosures →
EDGAR →
ESPR
Conviction 65HealthcareScan · Thu, Jun 25, 2026ESPR$3.15+0.00%
ResistanceSupportVol 14Insider sell3
Vol MA14 10.18M
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price3.15
Change+0.00%
Gap+0.16%
Rel volume1.09×
Avg volume11.02M
Avg $ vol34.66M
SMA 203.15
SMA 502.86
SMA 2003.03
Price vs 50+10.19%
Price vs 200+3.92%
MA stackmixed
50/200 cross—
Supertrendup · 3.09
RSI (14)66
MACD hist-0.02
MACD cross—
Stoch %K / %D50 / 59
ADX (14)39
+DI / −DI30 / 16
RSI divergence—
MACD divergence—
ATR %+0.95%
ADR %0.46%
52w high4.08
52w low0.9844
From 52w high-22.79%
Above 52w low+219.99%
New 52w highNo
SqueezeOn · 17d
Bollinger width1.48%
%B0.60
Donchian pos60.00%
Donchian high3.17
Donchian low3.12
AVWAP (52w high)2.98
vs AVWAP high+5.87%
AVWAP (52w low)2.85
vs AVWAP low+10.67%
OBV trendFlat
Chaikin MF (20)-0.02
Today vs 20d1.09×
Avg vol (14d)10.18M
Avg vol (20d)11.02M
Avg $ vol (20d)34.66M
Market cap810.91M
RS 3m (vs SPY)+7.97%
RS 6m (vs SPY)-27.58%
RS line new highNo
Trend template7/8
Technical rank51.8
1 week-0.63%
1 month+0.96%
3 months+14.13%
6 months-22.03%
1 year+194.39%
YTD-15.09%
P/E-35.75
P/B-2.63
P/S2.01
P/FCF-61.93
EPS-0.1100
Div yield—
ROE7.37%
ROA-4.90%
Debt/Eq-0.00
Current1.53
EV/EBITDA—
Gross margin—
Net margin-5.63%
Rev growth21.31%
EPS growth56.17%
Price target2.91
Target upside-7.62%
Analyst ratingHold
Institutional74.93%
Ent. value655.04M
Revenue80.1M
Net income-25.2M
Gross profit—
Free cash flow-13.09M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out—
Employees294
ListedWed, Jun 26, 2013
Free float234.07M
Float %97.9%
Short interest18.71M
Days to cover2.7d
Short volume36.7%
Squeeze score31 / 100
Next earningsTue, Aug 4, 2026 (40d)
EPS forecast−$0.02 · 3 est
Last EPS vs est−$0.10 vs −$0.04
Last surprise-150.0% miss
Setup gradeB
Conviction65 / 100
Pattern quality—
Tech rank51.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance3.17
Support3.12
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ESPR
No recent disclosed trades by Congress in ESPR. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ESPR · 5 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Halladay Benjamin Chief Financial Officer · Common Stock · 2026-06-17 | Sell | 10.77K | $34K | 2026-06-17 | 2026-06-18 |
Koenig Sheldon L. President and CEO · Common Stock · 2026-06-17 | Sell | 53.59K | $169K | 2026-06-17 | 2026-06-18 |
Looker Benjamin Chief Legal Officer · Common Stock · 2026-06-17 | Sell | 11.82K | $37K | 2026-06-17 | 2026-06-18 |
Hoffman Robert E. Director · Common Stock · 2026-05-28 | Grant | 79.87K | $0 | 2026-05-28 | 2026-06-01 |
THOMPSON JOHN CRAIG Director · Common Stock · 2026-05-28 | Grant | 79.87K | $0 | 2026-05-28 | 2026-06-01 |
CARROLL J MARTIN Director · Common Stock · 2026-05-28 | Grant | 79.87K | $0 | 2026-05-28 | 2026-06-01 |
Shepard Jay Director · Common Stock · 2026-05-28 | Grant | 79.87K | $0 | 2026-05-28 | 2026-06-01 |
Fischer Seth H. Z. Director · Common Stock · 2026-05-28 | Grant | 79.87K | $0 | 2026-05-28 | 2026-06-01 |
SEC filings
EDGAR filings in ESPR · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.